Poor Survival Rates for Renal Medullary Carcinoma Highlight Need for International Cooperation

Strategic Insights -

Recent research by the University of North Carolina Chapel Hill's Pediatric Surgical Oncology Research Collaborative has shed light on the poor survival rates of patients with renal medullary carcinoma (RMC), a type of aggressive tumor associated with sickle cell trait. The study, published in Pediatric Blood & Cancer, analyzed data from 34 patients diagnosed with RMC between 2000 and 2022. The findings highlight the need for coordinated international cooperative group studies to improve RMC survival.

Key Takeaways:

  • The median overall survival (OS) for patients with RMC was 24 months from diagnosis, with a significant difference between children (16 months) and adults (28 months).
  • The majority of patients (71%) were male, and 84% were Black, with 91% having sickle cell trait or disease.
  • Most patients (94%) presented with symptoms, and 79% had metastatic disease at diagnosis.
  • Receipt of platinum-based chemotherapy was associated with significantly higher OS compared to other regimens.
  • The study's lead author, Elisabeth T. Tracy, emphasized the need for coordinated international cooperation to improve RMC survival.

Statistics:

  • Median OS for RMC patients: 24 months (16 months for children, 28 months for adults).
  • Number of patients with RMC: 34.
  • Male patients: 24 (71%).
  • Black patients: 27 (84%).
  • Patients with sickle cell trait or disease: 30 (91%).
  • Patients presenting with metastatic disease: 27 (79%).
  • Patients who received platinum-based chemotherapy: 23 (68%).
  • Median OS for patients receiving platinum-based chemotherapy: 35 months.
  • Median OS for patients not receiving platinum-based chemotherapy: 5 months.

Sources:

  • Tracy, Eliasabeth T. et al. "Contemporary biology, management, and outcomes of renal medullary carcinoma in children and adults: A pediatric surgical oncology research collaborative study." Pediatric Blood & Cancer, 2025.
  • University of North Carolina Chapel Hill.